Peter Bou Dib: New Insights on Factor VIII and the Musculoskeletal System
Peter Bou Dib, Key Account Manager at Sino Biological Europe, shared on LinkedIn about a recent article by Antoine Babuty et al, published in Nature Bone Research:
”Hemophilia A (HA) has long been known as a bleeding disorder caused by deficient Factor VIII (FVIII), leading to life-impacting joint bleeds and muscle degeneration.
But what if FVIII’s role extends far beyond just stopping bleeds?
A recently published study using FVIII knockout mice uncovered a surprising story: FVIII deficiency triggers early osteoporosis, disrupted bone vascularization, and muscle abnormalities
a complex musculoskeletal disruption that mirrors patients’ real-life challenges.
Even more promising, intravenous recombinant FVIII treatment not only restored bone density and vascular health but partially reversed muscle metabolic defects.
This suggests FVIII acts as a critical regulator of bone remodeling and muscle metabolism, not just coagulation.
For those living with HA, these insights kindle hope for therapies that protect bones and muscles, improving quality of life beyond bleeding control.
Science is rewriting what we know about FVIII, transforming how we understand, treat, and support hemophilia.
The journey continues.”
Title: Factor VIII restores bone parameters and modulates muscle proteo-metabolome in Factor VIII knockout male mice
Authors: Antoine Babuty, Javier Muñoz-Garcia, Olivier D. Christophe, Laurie Fradet, Manon Taupin, Denis Cochonneau, Emilie Ollivier, Frank Driessler, Claudia Lange, Oleksandr Boychenko, Marie-Françoise Heymann, Dominique Heymann
Read the Full Article on Nature Bone Research

Stay updated on all scientific advances with Hemostasis Today.
-
Jun 24, 2026, 13:50Tijjani Balas: Why Early Detection of DVT Matters
-
Jun 24, 2026, 13:43Brandon Michael Henry: Interpreting Complement Activation After AAV Gene Therapy
-
Jun 24, 2026, 13:37Heba Youssef: Heparin-Induced Thrombocytopenia – The Prothrombotic Emergency You Cannot Miss
-
Jun 24, 2026, 13:32Jecko Thachil: Understanding the Clinical Spectrum of Vitamin B12
-
Jun 24, 2026, 13:32Namrata Singh: Beyond Low Platelets – Understanding What Triggers ITP
-
Jun 24, 2026, 09:29Advancing Women’s Health Through Collaboration with Jean Hailes for Women’s Health – Stroke Foundation
-
Jun 24, 2026, 09:18The Lasting Immunological Footprint of VITT – JTH
-
Jun 24, 2026, 09:09Umberto Pensato: Dedicated Funding Pathways for Stroke Research in Italy
-
Jun 24, 2026, 09:00Danny Gaskin: BBTS 2026 and the Evolving Role of Transfusion in Maternity Care